Is a normal CEA accurate following curative colorectal cancer surgery?  by Humphreys, Alexander K. et al.
Abstracts / International Journal of Surgery 9 (2011) 495–546 523
ABSTRACTSConclusions: Where both ultrasound and 99mTc sestamibi SPECT concur,
this increases the sensitivity of pre-operative localisation techniques in
minimally invasive parathyroidectomy.0295 IS A NORMAL CEA ACCURATE FOLLOWING CURATIVE
COLORECTAL CANCER SURGERY?
Alexander K. Humphreys, Julie A. Cornish, James Stevenson, Palanichamy
Chandran, Peter J. Billings. Wrexham Maelor Hospital, North Wales, UK
Background: There are no nationally agreed guidelines about carci-
noembryonic antigen (CEA) and computerised tomography (CT) for colo-
rectal cancer follow-up. The aim of this studywas to investigate timing and
incidence of recurrence on CT in patients with normal CEA's.
Methods: A retrospective cohort study of patients undergoing curative
colorectal cancer surgery 2006-2009. Patients were grouped by CEA into 3
groups; no rise, rise within normal limits, or elevated rise 2). Outcomes
included CT recurrence, time to CEA rise, time to CT recurrence and
mortality. Data analysis used SPSS v.18, Pearson Chi2, andMannWhitney U
tests.
Results: 440 patients were included, mean age 70.5 (range 29.0-97.42),
29%(n¼129) had rectal carcinomas and 59.8%(n¼263) were male. Median
time from surgery to ﬁrst CEA rise was 210 days(79-771) in Dukes' A/B vs.
Dukes' C/D, 131.5 days(15-1022);p<0.001. 17% (n¼28) with no CEA rise,
29.6%(n¼16) with a CEA rise within normal limits (<10) and 71.4%(n¼35)
with elevated CEA had disease on CT.13% (n¼11) Dukes' A/B preoperatively
with normal CEA's had recurrence, median time 210 days (range 79-771)
from surgery to CEA rise.
Conclusion: Follow-up of all patients should use CEA and CT.0298 EARLY HIGH CRP RISE PREDICTS MAJOR COMPLICATIONS AFTER
COLORECTAL SURGERY
Jeffrey Lim 1, Debabrata Roy 2, Andrew Huang 3. 1North Bristol NHS Trust,
Bristol, UK; 1Oxford Radcliffe Hospitals NHS Trust, Oxford, UK;
1Buckinghamshire Hospitals NHS Trust, Buckinghamshire, UK
Objective: Diagnosis of major complications after colorectal surgery is
often delayed and this delay contributes to increased morbidity and
mortality. The aim of this study is to monitor inﬂammatory markers that
can predict complications in the early post-operative period.
Methods: A retrospective study of 337 patients undergoing elective major
colorectal surgery from May 2006 to July 2010 by one surgeon was
undertaken. Patients were followed up after surgery and blood tests,
complications, interventions and outcomes were recorded. Patients were
grouped according to their post-operative complications.
Results: Twenty seven of 337 (8%) patients developed surgical complica-
tions after major colorectal resections at a mean of 7.5 post-operative days.
Other complication groups included wound infections (19.5%) and medical
complications (4.7%). The CRP level showed a peak at the third post-
operative day (158 + 0.64 vs. 114 + 0.19, p < 0.05) in the surgical compli-
cation group and remained signiﬁcantly higher (p < 0.05) compared to
patients with no surgical complication.
Conclusions: These data shows that an early high CRP rise in the early
post-operative period is an important indicator of major surgical compli-
cations such as anastomotic leak or abscess formation. This parameter may
be useful in earlier diagnosis of these complications.0299 A PARADOXICAL CASE
Arif Khokhar. Oxford University, Oxford, UK
Introduction: Acute ischaemic limbs commonly arise due to thrombo-
embolic disease. With the increasing diagnosis of cardiac shunts, the
possibility of paradoxical emboli causing arterial occlusion is higher.
Making this diagnosis can be difﬁcult as we highlight here.
Case-study: A 44 year old presentedwith a 3-day history of a progressively
cold, weak and numb left arm. He had diabetes, hypertension and hyper-
cholesterolaemia. For the past 6 months, he suffered from bloody diar-
rhoea and un-intentional weight loss. The left arm was cold and pale witha capillary reﬁll time >2s. Radial, ulnar and brachial pulses were un-
palpable. An emergency left brachial-embolectomy was carried out
establishing good inﬂow, outﬂow and perfusion. Over the next 24 hours,
he developed similar symptoms requiring two further brachial-
embolectomies.
Contrast echocardiography detected the presence of a patent foramen
ovale with right-to-left shunting. The diarrhoea and PR bleeding prompted
a sigmoidoscopy and histopathology conﬁrmed acute Ulcerative Colitis
(UC).
Conclusion: In our patient the UC resulted in a hyper-coagulable state,
forming venous thrombi. These thrombi led to multiple paradoxical
emboli through the formamen ovale, which subsequently occluded the
brachial artery. Therefore, in cases of recurrent acute limb ischaemia, the
presence of cardiac shunts should be sought as a possibile explanation.0301 A SYSTEMATIC REVIEW OF MID-TERM OUTCOMES OF THORACIC
ENDOVASCULAR REPAIR (TEVAR) OF CHRONIC TYPE B AORTIC
DISSECTION
Sri Thrumurthy, Alan Karthikesalingam, Ben Patterson, Peter Holt, Rob
Hinchliffe, Ian Loftus, Matt Thompson. St George's Vascular Institute,
London, UK
Introduction: Thoracic Endovascular Repair (TEVAR) in chronic type B
aortic dissection remains controversial and its mid-term superiority over
open repair and medical therapy remains unknown. Methods: Medline,
trial registries, conference proceedings and article reference lists were
searched to identify studies reporting mid-term outcomes of TEVAR for
chronic type B dissection.
Results: Seventeen studies (n¼567) were reviewed. The technical success
rate was 89.9% (range 77.6-100). Mid-term mortality was 9.2% (46/499);
survival ranged from 59.1-100% in studies with a median follow-up of 24
months. 8.1% of patients (25/309) developed endoleak, predominantly
type I. Re-intervention rates ranged from 0-60% in studies with a median
follow-up of 31 months. 7.8% (26/332) developed distal aortic aneurysms
or continued false lumen perfusion with aneurysmal dilatation. Rare
complications included delayed retrograde type A dissection (0.67%),
aorto-oesophageal ﬁstula (0.22%) and neurological complications (para-
plegia 2/447, 0.45%; stroke 7/475, 1.5%).
Conclusions: TEVAR for chronic type B dissection is technically feasible in
specialist centers. The lack of natural history data for medically treated
cases, signiﬁcant heterogeneity in case selection and absence of consensus
reporting standards for intervention are signiﬁcant obstructions to inter-
preting the mid-term data. High quality data from registries and clinical
trials are required to address this.0305 INTRAVESICAL BOTOX FOR OVERACTIVE BLADDER
Jerry Raju, Steven Foley. Royal Berkshire Hospital, Reading, UK
Aim: Overactive bladder (OAB) affects over 16% of those above 40 years.
Intravesical Botox has been shown to reduce void frequency, incontinence
episodes and improve quality of life in patients with OAB. Known
complications include urinary retention and need for intermittent self
catheterisation (ISC).
Method: This study examined the outcomes for 204 patients undergoing
a total of 323 intravesical Botox procedures, including 120 repeat proce-
dures in 69 patients, over 5 years. Two formulations of botulinum toxin
were used - Botox and Dysport.
Results:Mean administered dose of Botox was 195 IU and Dysport 613 IU.
Mean doses used decreased by 43% and 41% respectively between 2005
and 2009/10. 171 patients were followed up in clinic at 5.5 months (mean)
post procedure. 21 had further appointments 12 months post procedure
and 2 at 15 months. 79% reported symptom improvement. The effect had
worn off in 30% at 5.5 months, 70% at 12 months and 100% at 15 months.
Need for ISC was documented in 18% of cases. There was no correlation
between Botox dose and ISC.
Conclusion: Botox is an effective treatment for OAB. The effect lasts on
average 5-10 months and repeat doses are often required. Approximately
one ﬁfth will require ISC.
